Electronics Weekly
The work will be conducted within a number of groups at MIT including the Research Lab of Electronics (RLE), Microsystems Technology Laboratories (MTL) and the Institute for Medical Engineering and Science (IMES).
Healthcare remains one of the most significant global socio-economic challenges, particularly as life expectancy increases. Achieving personalized treatment through tailored monitoring of vital signs and biomarkers has proven challenging but essential. Recent progress in semiconductor technology has brought us closer to this objective.
To harness this potential, imec and MIT researchers are combining their leadership in nanoelectronics and semiconductor technology. The agreement, signed this week, formalizes their commitment to address common healthcare challenges by uniting pioneering researchers within the semiconductor and life sciences ecosystem.
“We believe that by integrating cutting-edge semiconductor technology and AI, our collaboration with MIT has the ability to revolutionize healthcare,” says imec’s Veerle Reumers (pictured left with MIT’s Brian Anthony) “with MITs healthcare and microsystems expertise, and imec as the gold-standard for transferring novel technologies to industry, this partnership combines decades of complementary experience. We are excited about improving healthcare through technology solutions for personalized medicine and the potential impact on people’s quality of life.”
The collaboration aims to develop nanoelectronics-based, minimally-invasive diagnostic devices capable of monitoring biomarkers and vital signs in clinical, point-of-care, or home settings.
When combined with AI, these data enable the creation of an individual’s digital biological profile that can facilitate detailed clinical monitoring. This provides clinicians with powerful tools for therapy, diagnosis, and prevention of diseases, ultimately enhancing quality of life.
